In recent years the interest in and acceptance of decentralized clinical trials and supporting technologies has seen significant growth. With new eClinical innovations constantly released, Sponsors concerned about the potential risks of adopting eClinical technologies to enable DCTs must seek out technology partners who are experts and can take the worry out of making the investment and implementing significant changes. But what does expertise look like, particularly with innovations that are still quite new?  

This article provides a short litmus test that can be applied to find the experts and ensure success when selecting eClinical technology partners. 

Fill out this form to download the Whitepaper